PMID- 11498801 OWN - NLM STAT- MEDLINE DCOM- 20011004 LR - 20191025 IS - 0895-8378 (Print) IS - 0895-8378 (Linking) VI - 13 IP - 8 DP - 2001 Aug TI - Recovery from oxidant-mediated lung injury: response of metallothionein, MIP-2, and MCP-1 to nitrogen dioxide, oxygen, and ozone exposures. PG - 689-702 AB - Oxidant-induced lung injury is believed to be mediated by reactive oxygen species. Recovery from oxidant exposure has been associated with pulmonary inflammation. Inflammatory cell accumulation involves the synthesis of chemokines, including neutrophil chemoattractants such as macrophage inflammatory protein-2 (MIP-2) and monocyte chemoattractants such as monocyte chemoattractant protein-1 (MCP-1). Antioxidants are the first line of defense of lung cells against inhaled oxidants. Metallothionein (MT) can act as an antioxidant and free-radical scavenger. To better understand the pulmonary response associated with recovery from oxidant-mediated injury, we exposed mice to either 15 ppm nitrogen dioxide for 24 h, >99% oxygen for 72 h, or 1 ppm ozone for 24 h. Mice were examined at the end of exposure or after recovering in room air for 4 or 24 h. Neutrophils were elevated at the end of exposure and remained elevated through the postexposure period, whereas macrophage numbers were decreased at the end of exposure and remained below control levels at 4 and 24 h postexposure. MT, MIP-2, and MCP-1 mRNA levels were elevated at 4 h postexposure; however, after 24 h of recovery only MCP-1 remained elevated. These results indicate that MT, MIP-2, and MCP-1 mRNA levels responded similarly to recovery from nitrogen dioxide, oxygen, and ozone exposure. Monocyte accumulation was delayed as compared to neutrophils and was consistent with the timing of MIP-2 and MCP-1 expression. Peak expression of MT and MIP-2 preceded peak neutrophil accumulation. Consequently, the timing of MT, MIP-2, and MCP-1 expression may be important biological markers in assessing the state of injury and recovery associated with oxidant-mediated injury. FAU - Johnston, C J AU - Johnston CJ AD - Department of Environmental Medicine, University of Rochester, 601 Elmwood Avenue, Box 777, Rochester, NY 14642, USA. FAU - Oberdorster, G AU - Oberdorster G FAU - Finkelstein, J N AU - Finkelstein JN LA - eng GR - ESO1247/ES/NIEHS NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - England TA - Inhal Toxicol JT - Inhalation toxicology JID - 8910739 RN - 0 (Chemokine CCL2) RN - 0 (Chemokine CXCL2) RN - 0 (Chemotactic Factors) RN - 0 (Monokines) RN - 0 (Oxidants, Photochemical) RN - 0 (RNA, Messenger) RN - 66H7ZZK23N (Ozone) RN - 9038-94-2 (Metallothionein) RN - S7G510RUBH (Nitrogen Dioxide) RN - S88TT14065 (Oxygen) SB - IM MH - Administration, Inhalation MH - Animals MH - Bronchoalveolar Lavage MH - Bronchoalveolar Lavage Fluid/chemistry/cytology MH - Chemokine CCL2/*metabolism MH - Chemokine CXCL2 MH - Chemotactic Factors/*metabolism MH - In Situ Hybridization MH - Lung Diseases/*chemically induced/*metabolism/pathology MH - Male MH - Metallothionein/*metabolism MH - Mice MH - Mice, Inbred C57BL MH - Monokines/*metabolism MH - Nitrogen Dioxide/*toxicity MH - Nuclease Protection Assays MH - Oxidants, Photochemical/*toxicity MH - Oxygen/*toxicity MH - Ozone/*toxicity MH - RNA, Messenger/biosynthesis EDAT- 2001/08/11 10:00 MHDA- 2001/10/05 10:01 CRDT- 2001/08/11 10:00 PHST- 2001/08/11 10:00 [pubmed] PHST- 2001/10/05 10:01 [medline] PHST- 2001/08/11 10:00 [entrez] AID - 10.1080/08958370126867 [doi] PST - ppublish SO - Inhal Toxicol. 2001 Aug;13(8):689-702. doi: 10.1080/08958370126867.